Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-30

FDA Approved: AZELASTINE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approves a supplemental application for azelastine submitted by Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZELASTINE (Azelastine)

Snippet

SUPPL AP for AZELASTINE (AZELASTINE)